Cholesterol Metabolism in CKD

American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
Allison B ReissJoseph Mattana

Abstract

Patients with chronic kidney disease (CKD) have a substantial risk of developing coronary artery disease. Traditional cardiovascular disease (CVD) risk factors such as hypertension and hyperlipidemia do not adequately explain the high prevalence of CVD in CKD. Both CVD and CKD are inflammatory states and inflammation adversely affects lipid balance. Dyslipidemia in CKD is characterized by elevated triglyceride levels and high-density lipoprotein levels that are both decreased and dysfunctional. This dysfunctional high-density lipoprotein becomes proinflammatory and loses its atheroprotective ability to promote cholesterol efflux from cells, including lipid-overloaded macrophages in the arterial wall. Elevated triglyceride levels result primarily from defective clearance. The weak association between low-density lipoprotein cholesterol level and coronary risk in CKD has led to controversy over the usefulness of statin therapy. This review examines disrupted cholesterol transport in CKD, presenting both clinical and preclinical evidence of the effect of the uremic environment on vascular lipid accumulation. Preventative and treatment strategies are explored.

References

May 1, 1992·European Journal of Epidemiology·B G Nordestgaard, A Tybjaerg-Hansen
Sep 1, 1987·Kidney International·P O AttmanA Gustafson
Sep 18, 1996·JAMA : the Journal of the American Medical Association·C D GardnerR M Krauss
Jun 3, 1999·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·H J MilionisK C Siamopoulos
May 31, 2002·Clinical Nephrology·M J SarnakA S Levey
Dec 17, 2002·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·James R MeadDipak P Ramji
Feb 7, 2003·Journal of the American College of Cardiology·Guruprasad ManjunathMark J Sarnak
Apr 5, 2003·Kidney International·Nosratola D Vaziri
Jun 24, 2003·Journal of the American Society of Nephrology : JASN·Peter StenvinkelBengt Lindholm
Oct 29, 2003·Circulation·Mark J SarnakUNKNOWN American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology,
Jan 30, 2004·JAMA : the Journal of the American Medical Association·Yongmei LiuMichael J Klag
Sep 24, 2004·The New England Journal of Medicine·Alan S GoChi-yuan Hsu
Oct 16, 2004·Reviews in Endocrine & Metabolic Disorders·Benjamin J AnsellAlan M Fogelman
May 14, 2005·Current Opinion in Lipidology·Miranda Van EckTheo Jc Van Berkel
Sep 17, 2005·Kidney International·Vandana MenonMark J Sarnak
Sep 27, 2005·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Srinivasan BeddhuAlfred K Cheung
Jan 13, 2006·American Journal of Physiology. Renal Physiology·N D Vaziri
Apr 14, 2006·Kidney International·H YamamotoE Kusano
Aug 26, 2006·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Daniel E WeinerMark J Sarnak
Nov 30, 2006·Journal of the American Society of Nephrology : JASN·Eberhard Ritz, Christoph Wanner
Dec 5, 2006·The Journal of Clinical Investigation·Daniel J Rader
Jul 28, 2007·The Journal of Clinical Investigation·Xun WangDaniel J Rader
Sep 29, 2007·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Joan C LoGeorge A Kaysen
Nov 8, 2007·JAMA : the Journal of the American Medical Association·Josef CoreshAndrew S Levey
Nov 30, 2007·American Journal of Nephrology·Michel ChoncholNancy R Kressin
Jan 11, 2008·Clinical Journal of the American Society of Nephrology : CJASN·Peter StenvinkelZiad Massy
Mar 14, 2008·Current Drug Targets·Jonathan E FeigEdward A Fisher
May 22, 2008·Atherosclerosis·Tetsuo ShojiYoshiki Nishizawa
Jan 6, 2009·Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation·Gulinuer MuteliefuToshimitsu Niwa
Aug 22, 2009·Clinical Journal of the American Society of Nephrology : CJASN·Fellype C BarretoUNKNOWN European Uremic Toxin Work Group (EUTox)
Sep 17, 2009·European Journal of Clinical Pharmacology·Jianyong WuJianghua Chen
Sep 22, 2009·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Toshiaki NakanoKatsuo Sueishi

❮ Previous
Next ❯

Citations

Sep 3, 2016·American Journal of Human Genetics·Anubha MahajanNora Franceschini
Aug 26, 2017·Arteriosclerosis, Thrombosis, and Vascular Biology·Archna BajajUNKNOWN Chronic Renal Insufficiency Cohort (CRIC) Study Investigators*
Oct 27, 2018·Nature Reviews. Nephrology·Charles J FerroCarmine Zoccali
Mar 13, 2019·International Journal of Molecular Sciences·Agnieszka KuchtaMaciej Jankowski
Mar 13, 2019·Journal of the American Heart Association·Ki Heon NamUNKNOWN KNOW‐CKD (KoreaN Cohort Study for Outcomes in Patients With Chronic Kidney Disease) Investigators
Oct 13, 2017·Journal of the American Society of Nephrology : JASN·Farsad AfshinniaUNKNOWN Michigan Kidney Translational Core CPROBE Investigator Group
May 2, 2019·Journal of the American Society of Nephrology : JASN·Luca ZanoliPierre Boutouyrie
Aug 16, 2019·Arteriosclerosis, Thrombosis, and Vascular Biology·José M ValdivielsoAlberto Ortiz
Dec 5, 2017·Experimental and Therapeutic Medicine·Jing TianXinjiang An
Dec 22, 2016·Reviews in Endocrine & Metabolic Disorders·Matthew R HagerLisa R Tannock
Sep 11, 2020·International Journal of Molecular Sciences·Linsey J F PetersEmiel P C van der Vorst
Sep 8, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Ling HuJian-Hua Ran
Oct 1, 2020·European Journal of Clinical Nutrition·Yang WangJian-Jun Mu
Nov 23, 2019·Nutrients·Anna Gluba-BrzozkaJacek Rysz
Feb 25, 2021·Clinical Kidney Journal·Soie KwonSeung Seok Han
Oct 15, 2020·International Journal of Molecular Sciences·You-Jin KimYong-Lim Kim
Apr 28, 2018·Journal of Clinical Lipidology·Sankar D NavaneethanJoseph V Nally
Mar 30, 2021·Expert Review of Proteomics·E MavrogeorgisJ Siwy
Mar 8, 2021·The Journal of Clinical Endocrinology and Metabolism·Chieh-Li YenChih-Hsiang Chang
Jul 17, 2021·Frontiers in Medicine·Isha SharmaYashpal S Kanwar
Aug 10, 2021·Journal of the American Heart Association·Jae Young KimUNKNOWN KNOW‐CKD (Korean Cohort Study for Outcomes in Patients With Chronic Kidney Disease) Investigators

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

Carotid Artery Diseases

Carotid artery disease is a group of pathological conditions of the carotid artery. Discover the latest research on carotid artery disease here.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Cell Adhesion Molecules in AS

Cell adhesion molecules expressed on the vascular endothelium and circulating leukocytes in response to inflammatory stimuli are implicated in atherosclerosis. Here is the latest research.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.